AUTOLOGOUS CONDITIONED PLASMA
Injection Site
Star Spine and Sportother_biologicalPhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 95/ 100
Competitive context
5 Active assets in the Injection Site cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ROPIVACAINE Claus Anders Bertelsen, PhD, MD | Phase 4 | BB |
LIDOCAINE Cairo University | N/A | D |
FENTANYL Cairo University | N/A | D |
MIDAZOLAM Cairo University | N/A | D |
DEXTROSE Cairo University | N/A | D |
PROPOFOL Cairo University | N/A | D |
Same molecule, other indications
AUTOLOGOUS CONDITIONED PLASMA is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →